Press Release HOME > NEWS > Press Release [ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation. READ MORE PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards. READ MORE South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO. READ MORE PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect. READ MORE PharmCADD Raised $16M in Series B Funding. READ MORE Eyegene published a nonclinical paper COVID-19 vaccine on BioRxiv. READ MORE PharmCADD showed AI drug development platform, Pharmulator at AI EXPO in korea. READ MORE PharmCADD provided scholarship to the Department of Physics at Pukyong National University READ MORE [New drug development using AI] Molecular design using generative models READ MORE « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
[ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation. READ MORE
PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect. READ MORE